Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04876846 · ClinicalTrials.gov registry record · NA
Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity
A NA study, sponsored by Raydiant Oximetry.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT04876846: Completed NA study, sponsored by Raydiant Oximetry.
NCT04876846 is a NA study that has completed, run by Raydiant Oximetry. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04876846, a NA study, has completed, sponsored by Raydiant Oximetry.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The overall purpose of this study is to evaluate maternal-fetal tissue light scattering properties. The objectives of the study are: (i) integrate established mathematical principles of oxygen saturation to model with increasing accuracy the "body in a body" problem of fetus in mother; similar to existing pulse oximeters, the calculations will be integrated into software in the final commercial product; (ii) obtain human measurements against which both computational models and animal data can be compared.
Primary Outcome
Correlation of the fetal doppler signal with the ROSS device optional fetal signal.
Interventions
- DEVICE GEN 3 Monitoring of Fetus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-04-24 |
| Est. Completion | 2025-11-11 |
| Phase | NA |
What the finished NCT04876846 record still lists
NCT04876846 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which GEN 3 Monitoring of Fetus is the first listed.
NCT04876846 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04876846 about?
NCT04876846 is a clinical study titled "Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity". The overall purpose of this study is to evaluate maternal-fetal tissue light scattering properties. The objectives of the study are: (i) integrate established mathematical principles of oxygen saturation to model with increasing accuracy the "body in a body" problem of fetus in mother; similar to ex...
What is the current status of trial NCT04876846?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2021-04-24. Estimated completion is 2025-11-11.
What interventions are being tested in trial NCT04876846?
The interventions under investigation include: GEN 3 Monitoring of Fetus (DEVICE).
Who is sponsoring clinical trial NCT04876846?
This trial is sponsored by Raydiant Oximetry, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04876846's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI